Benjamin Mittman has joined Troutman Pepper Locke's Private Equity and Investment Funds Practice Group in Philadelphia.

On May 1st, the global blockchain industry event Token2049 concluded successfully, marking a significant moment for Web3 and ...

Mythics, LLC, an award- winning Oracle systems integrator, announced today that they have acquired SpearMC, a leading provider of PeopleSoft Managed Services, Consulting and Training. This acquisition ...

Rentana, an AI-driven revenue intelligence platform for multifamily owners and operators, today announced the close of a nearly $5 million seed funding round led by Zigg Capital and Benchstrength.

Caresyntax Corporation, a leader in surgical data integration and intelligence, and The Jacobs Institute, Inc. (JI), a not-for-profit vascular medical technology innovation center, today announced a ...

With four in ten Americans saying they have seriously considered moving out of the U.S. in the next two years, the importance of having reliable, affordable international health insurance comes into ...

Celebration serves as a continuation of the company's ongoing support of U.S. military veterans as it prepares for its second Honor Flight later this year CLEARWATER, FLORIDA / ACCESS Newswire / May 6 ...

In response to today's high demand for resilience in the world of physical operations, Samsara Inc. ("Samsara") , the pioneer of the Connected Operations® Platform, announced its new Upgrade for ...

Netsmart announces the launch of Bells Quality Coach, an augmented intelligence (AI) solution designed to enhance the efficiency and effectiveness of documentation processes within healthcare ...

Prestige Auctions, in conjunction with Holland Industrial Group, is pleased to announce a 3-day online auction event, offering the complete assets of a leading U.S. firearms manufacturer.  This ...

Sangamo Therapeutics, Inc. , a genomic medicine company, today announced important derisking events in the pathway to a planned BLA submission for isaralgagene civaparvovec, or ST-920, its wholly ...

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced its participation ...